Sunday, March 15, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Vaccine disinformation continues to rise

Far-right extremists behind election disinformation are now pivoting to spreading alarmist warnings and misinformation about COVID-19 vaccines, according to a New York Times investigation.

“They rode the shift in the national conversation away from Trump to what was happening with the massive ramp up in vaccines,” Devin Burghart, the head of the Seattle-based Institute for Research and Education on Human Rights, told the New York Times, referring to followers of QAnon. “It allowed them to pivot away from the failure of their previous prophecy to focus on something else.”

Public health officials have been warning about the dangers of vaccine misinformation as the country seeks to inoculate enough Americans to reach herd immunity. Just this week the CEOs of Facebook, Google and Twitter were questioned before Congress on their responsibility to combat disinformation spread on their platforms as well as their role in the organization of the insurrection on the United States Capitol. Ahead of the hearing, a group of 12 state attorneys general sent a letter to Facebook and Twitter calling for “immediate steps to fully enforce your companies’ guidelines against vaccine misinformation.”

A recent report from the Center for Countering Digital Hate and Anti-Vax Watch found that most of the anti-vaccine content circulating online can be tied to 12 people, several of whom are figures in the health and wellness spheres. But The New York Times investigation found that far-right groups are increasingly joining the anti-vaccination movement, fueled by a mistrust in the government.

Source: The Hill

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!